Michelena, Xabier http://orcid.org/0000-0002-5352-919X
Marzo-Ortega, Helena http://orcid.org/0000-0002-9683-3407
Article History
First Online: 24 October 2019
Competing interests
: X.M. declares that he has received speaking fees from Novartis, Sanofi and UCB. H.M.-O. declares that she has received research grants, honoraria and/or speaking fees from AbbVie, Celgene, Eli-Lilly, Janssen, Novartis, Pfizer and UCB and that she is a co-author of the 2016 ASAS–EULAR management recommendations for axial spondyloarthritis and a medical advisor to the Spondylitis Association of America.